The treatment developed by Sioux Falls-based SAB Biotherapeutics for the virus that causes COVID-19 has shown “effective and potent” ability to neutralize multiple variants of concern, including the Delta and Lambda variants.
She’s an entrepreneur whose winning pitch stood out at Startup Sioux Falls – and whose business helping people relocate has lots of room to grow.
“There’s a lot to love.” A fashion-tech company started by USD students is among those funded by local angel investors.
Graduation Day has come! Meet the entrepreneurs who now have completed the CO.STARTERS program.
Sanford Health vascular surgeon Dr. Patrick Kelly has invented a unique device to transform treatment of blood clots in the lungs that kill as many as 100,000 Americans each year.
SAB Biotherapeutics is moving ahead with clinical trials for its influenza treatment.
We love getting to know new businesses! Meet three who are finding lots of value participating in the Startup Sioux Falls CO.STARTERS program.
South Dakota is preparing to host one of the largest science experiments ever attempted on U.S. soil – underground. Come with us for a look at what’s happening at the Sanford Underground Research Facility.
Sioux Falls-based SAB Biotherapeutics plans to merge with a Miami-based firm, which will allow it to trade on the Nasdaq.
Bioscience education, research and development didn’t stop in 2020 – and this is your chance to catch up on what has been happening.
